NIH-funded research R01 grant

2D and 3D Ultrasound to Improve Chemoembolization in Liver Cancer

Official title: 2D and 3D Contrast-enhanced Ultrasound Evaluation of Chemoembolization.

Funded at Thomas Jefferson University · NIH-11401124 · Data updated 2026-11-12

A patient-friendly look at using advanced ultrasound to better guide chemoembolization for liver cancer and ensure fewer repeat procedures.

More Ultrasound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMarch 23, 2016
Project endJuly 31, 2029
Funding year2026
Award (this year)$1,704,809
NIH project number4R01CA194307-08
Project IDNIH-11401124 on NIH RePORTER

Who could benefit from this research

Could help

Adults with liver cancer (HCC or other liver tumors) treated with TACE who may need close imaging follow-up.

Less likely to help

Patients not undergoing TACE or without liver tumors would not directly benefit from this imaging-focused study.

What this research studies

This project tests 2D and 3D contrast-enhanced ultrasound (CEUS) to monitor and improve transarterial chemoembolization (TACE) for liver cancers, aiming to catch residual disease earlier than standard CT/MRI methods. By comparing CEUS to CT/MRI across multiple centers, the study seeks to show whether CEUS can help doctors decide if retreatment is needed sooner. The work builds on prior findings that CEUS detects remaining tumor activity more sensitively, potentially reducing unnecessary imaging delays. If CEUS proves reliable, it could change follow-up care and help transplant candidates receive timely, personalized treatment.

Why it matters

Potential benefit: Patients could experience earlier detection of residual disease and more timely retreatment, improving outcomes and potentially preserving transplant options.

How similar studies have gone: Earlier CEUS studies showed higher sensitivity for detecting residual disease after TACE compared with CT/MRI.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Eisenbrey, John — Thomas Jefferson University
  • Study coordinator: Eisenbrey, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.